IO Biotech, Inc. cotiza a 0.00 USD y tiene una capitalización bursátil de $14390. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment…
| Periodo | 2025-11 | 2025-08 | 2025-05 | 2025-03 |
|---|---|---|---|---|
| Real | $-0.13 | $-0.33 | $-0.32 | $-0.45 |
| Estimado | $-0.37 | $-0.30 | $-0.23 | $-0.38 |
| Sorpresa | +64.9% | -10.0% | -39.1% | -18.4% |
| Métrica | IOBTQ | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -203.1% | -40.4% | -162.7% |
| ROA | -141.1% | -32.0% | -109.0% |
| Current Ratio | 3.33 | 2.84 | +0.49 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |